Faculty profile

Jean-Paul Bahary

Back to faculty

ProfessorDépartement de radiologie, radio-oncologie et médecine nucléaireUniversité de Montréal

Jean-Paul Bahary

Professor

Département de radiologie, radio-oncologie et médecine nucléaire

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
19 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

5,212

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Radiothérapie

Latest papers

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer
European Urology Oncology · 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology
JCO Precision Oncology · 2026
Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy
International Journal of Radiation Oncology Biology Physics · 2025

All 59 publications

Latest funding

A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer
CIHR · 2010 · Co-investigator
$300,236
A National "Patterns of Care" Study in Prostate Cancer Radiation Therapy: Development and Use of Quality Indicators
CIHR · 2008 · Co-investigator
$249,374

All 2 grants and awards

59 publications.

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer

Sanmamed N, Dayes I, Catton C, Liu A, Supiot S, Lukka H, Bauman G, Liu Z, Bahary J-P, Ahmed S

European Urology Oncology20265 citations

DOI: 10.1016/j.euo.2025.03.017

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology

Kamran SC, Borges M, Michalski J, Lee WR, Sandler HM, Crook J, Pollack A, Hurwitz MD, Valicenti RK, Bruner DW

JCO Precision Oncology2026Open Access

DOI: 10.1200/po-26-00158

Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy

Lukka HR, Pugh SL, Shipley WU, Major PP, Sartor O, Dayes IS, Bahary J-P, Efstathiou JA, Pisansky TM, Zeitzer KL

International Journal of Radiation Oncology Biology Physics20259 citationsOpen Access

DOI: 10.1016/j.ijrobp.2025.07.1416

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma

Jessica L. Fleming, Stephanie L. Pugh, Susan Marina Chang, Joseph Paul McElroy, Aline Paixão Becker, Kenneth Aldape, Helen Alice Shih, Lynn Stuart Ashby, Grant Kirton Hunter, Jean-Paul Bahary, Christopher J. Schultz, Brian D. Kavanagh, Vinay K. Puduvalli, H. Ian Robins, Maria Werner‐Wasik, Minesh P. Mehta, Arnab Chakravarti

International Journal of Radiation Oncology*Biology*Physics20254 citationsOpen Access

DOI: 10.1016/j.ijrobp.2025.03.043 PMID: 40164352

Outcomes of CyberKnife Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis.

Guillemette A, Roberge D, Ménard C, Bahary JP, Bou Assi E, Nguyen DK, Obaid S, Fournier-Gosselin MP

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques20253 citationsOpen Access

DOI: 10.1017/cjn.2025.37 PMID: 40026079

Symptomatic posttreatment edema after stereotactic radiotherapy (SRS/FSRS) for intracranial meningiomas: patterns and predictive factors.

Aissaoui D, Oulmoudne N, Bahig H, Masucci GL, Moumdjian R, Roberge D, Menard C, Létourneau-Guillon L, Lambert C, Bahary JP

Clinical and translational radiation oncology20251 citationsSenior authorOpen Access

DOI: 10.1016/j.ctro.2025.101010 PMID: 40687732

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

Chan E, Pugh SL, Simko JP, Feng F, Shipley WU, Lukka HR, Bahary J, Pisansky TM, Zeitzer KL, Gore E

Prostate20251 citationsOpen Access

DOI: 10.1002/pros.70018

Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.

Morgan TM, Ren Y, Tang S, Zwerink W, Chen E, Mitani A, Huang HC, Simko JP, DeVries S, Pollack A, Wilke D, Martin AG, Balogh AG, Michalski JM, Greenberg MJ, Efstathiou JA, Bahary JP, Ross AE, Esteva A, Royce TJ, Nguyen PL, Hoffman KE, Sandler HM, Tran PT, Pugh SL, Feng FY, Spratt DE

European urology2025

DOI: 10.1016/j.eururo.2025.12.007 PMID: 41436315

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Tward JD, Huang HC, Esteva A, Mohamad O, van der Wal D, Simko JP, DeVries S, Zhang J, Joun S, Showalter TN, Schaeffer EM, Morgan TM, Monson JM, Wallace JA, Bahary JP, Sandler HM, Spratt DE, Rodgers JP, Feng FY, Tran PT

JCO precision oncology2024

DOI: 10.1200/po.24.00145 PMID: 39447096

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.

Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F

European urology2024

DOI: 10.1016/j.eururo.2023.01.020 PMID: 36710205

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jean-Paul Bahary

Research

Latest papers

Latest funding

Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology

Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma

Outcomes of CyberKnife Radiosurgery for Trigeminal Neuralgia in Patients with Multiple Sclerosis.

Symptomatic posttreatment edema after stereotactic radiotherapy (SRS/FSRS) for intracranial meningiomas: patterns and predictive factors.

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.

A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer

A National "Patterns of Care" Study in Prostate Cancer Radiation Therapy: Development and Use of Quality Indicators

Frequent collaborators

Guila Delouya

Himu Lukka

David Roberge

Barbara Fisher

Malti Patel

Ian Stuart Dayes

Anthony Whitton

Jeffrey Greenspoon

Kenneth Aldape

Michal Abrahamowicz

Jean-François Carrier

Theos Tsakiridis

Jean-Pierre Guay

Eric Vigneault

Houda Bahig

Michael Lock

Maroie Barkati

Glenn Bauman

Patrick Cheung

Padraig Warde